𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug–excipient interactions in ketoprofen: A vibrational spectroscopy study

✍ Scribed by L. A. E. Batista de Carvalho; M. Paula M. Marques; John Tomkinson


Publisher
Wiley (John Wiley & Sons)
Year
2006
Tongue
English
Weight
155 KB
Volume
82
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Ketoprofen (3‐benzoyl‐α‐methylbenzeneacetic acid) is a widely used nonsteroidal anti‐inflammatory drug (NSAID), always administered in the form of drugexcipient physical mixtures (PMs). The occurrence of possible interactions between ketoprofen and two commonly used excipients—lactose (LAC) and polyvinylpyrrolidone (PVP)—was evaluated, through vibrational spectroscopy techniques [both Raman and Inelastic Neutron Scattering (INS)]. Spectral evidence of drug:excipient close contacts, which were enhanced by aging, was verified for the (1:1) (w:w) (ketoprofen:PVP) and (ketoprofen:LAC) PMs, both by Raman and INS. These interactions were found to involve mainly the central carbonyl and the terminal methyl‐carboxylic moieties of the ketoprofen molecule, this being reflected in particular vibrational modes, such as the methyl torsion, the out‐of‐plane COH bending, and the inter‐ring CO stretching. © 2006 Wiley Periodicals, Inc. Biopolymers 82: 420–424, 2006

This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at [email protected]


📜 SIMILAR VOLUMES


Mirtazapine and paroxetine: a drug-drug
✍ F. J. L. Ruwe; R. A. Smulders; H. J. Kleijn; H. L. A. Hartmans; J. M. A. Sitsen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Paroxetine inhibits cytochrome P(450) 2D6, which is involved in the metabolism of mirtazapine. The possible drug-drug interaction between two pharmacologically distinct antidepressants, mirtazapine and paroxetine, has been investigated in a randomized, three-way crossover study in 24 healthy male an

Mirtazapine in combination with amitript
✍ C. Sennef; C. J. Timmer; J. M. A. Sitsen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## Objective To assess the steady‐state pharmacokinetics of mirtazapine (30 mg/day orally) and amitriptyline (75 mg/day orally) during combined administration compared with that of either drug administered alone. To evaluate the tolerability and effects on psychometric tests of acute a